Rituximab therapy and autoimmune disorders: Prospects for anti–B cell therapy

This publication has 49 references indexed in Scilit:

• Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
  Blood, 2003
• B cell–ablative therapy for the treatment of autoimmune diseases
  Arthritis & Rheumatism, 2002
• Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment
  Blood, 2002
• Rituximab in a case of cold agglutinin disease
  British Journal of Haematology, 2001
• Effects of specific anti‐B and/or anti‐plasma cell immunotherapy on antibody production in baboons: depletion of CD20‐ and CD22‐positive B cells does not result in significantly decreased production of anti‐αGal antibody
  Xenotransplantation, 2001
• Remission of severe cold agglutinin disease Rituximab therapy
  Leukemia, 2001
• A B Cell Superantigen–Induced Persistent “Hole” in the B-1 Repertoire
  The Journal of Experimental Medicine, 2000
• American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
  Arthritis & Rheumatism, 1995
• CD20: a regulator of cell-cycle progression of B lymphocytes
  Immunology Today, 1994
• Treatment of Murine Lupus with CTLA4Ig
  Science, 1994